United Therapeutics CEO Executes Pre-Arranged Stock Sales Under 10b5-1 Plan
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), executed a sale of 9,500 shares on June 16, 2026, generating approximately $5.22 million. The transaction was facilitated through a pre-arranged 10b5-1 trading plan established on November 7, 2025. Concurrently, Rothblatt exercised stock options to acquire an equiv…